AI scribes and adoption pathways

In this episode of Talking HealthTech, Peter Birch speaks with Julie Hoare, VP and Regional General Manager for APAC, Angela Ryan, Lead Healthcare Executive for APAC, and Amita Malik, Senior Director and Health Sciences Product Manager at Oracle Health and Life Sciences.

Together, they explore the evolution from Cerner to Oracle Health and the addition of Oracle Health Life Sciences, highlighting how these changes are shaping clinical trials, healthcare research, and patient care in Australia.

The conversation examines the challenges facing clinical trials, including fragmented systems, slow recruitment, and complex regulatory processes, and how data and AI are being used to address these issues.

The episode also covers the practical application of AI, the importance of trust and governance in digital tools, and the future direction of Oracle Health and Life Sciences in the region.

Key Takeaways

🧩 Fragmented healthcare and research data remain a barrier to efficient clinical trials and patient outcomes, highlighting the need for unified platforms.

🤖 AI and analytics are being used to automate patient-trial matching, improve data quality, and accelerate research outcomes.

📊 Leveraging existing EHR data can transform organisations from record-keepers to research-ready institutions, facilitating faster drug development.

💡 Building trust in AI adoption is essential, emphasising the role of clinician validation and evidence-based implementation.

🌏 Oracle Health is actively collaborating with industry and government to advance the safe, effective use of AI and unified data in health.

Timestamps

00:00 – Introductions & episode overview

03:23 – Challenges in clinical trials in Australia

07:54 – The evolution from Cerner to Oracle Health

12:59 – AI’s role in healthcare data & trials

18:06 – Clinical and practical use cases of AI

19:56 – Building trust in AI and digital tools

25:20 – AI Centre of Excellence and future directions

---------

Want to keep the conversation going?

The full article and extended show notes for this episode are available inside the THT+ Community here: View Full Article Here

In the THT+ Community, our members keep the discussion going, share perspectives, and unpack what this episode actually means in practice with other people working in healthtech.

If you’re enjoying the show and want access to full articles, episode discussions, meetups, and member-only content, you can learn more about becoming a THT+ Solo Member here: talkinghealthtech.com/thtplus.

And if this episode was useful, leaving a review or sharing it with someone in the industry always helps.